Assembly Biosciences (ASMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 58,450 | 38,344 | 19,841 | 52,418 | 45,627 |
| Marketable Securities | 189,656 | 73,735 | 110,406 | 39,192 | 101,000 |
| Receivables | 974 | N/A | 43 | 944 | 336 |
| TOTAL | $254,549 | $115,503 | $133,787 | $96,967 | $154,204 |
| Non-Current Assets | |||||
| PPE Net | 221 | 284 | 385 | 743 | 1,139 |
| Investments And Advances | 0 | 0 | 0 | 0 | 27,972 |
| Other Non-Current Assets | 2,820 | 3,381 | 2,651 | 4,084 | 7,745 |
| TOTAL | $3,041 | $3,665 | $3,036 | $4,827 | $36,856 |
| Total Assets | $257,590 | $119,168 | $136,823 | $101,794 | $191,060 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,171 | 585 | 461 | 2,493 | 2,659 |
| Accrued Expenses | 10,136 | 9,135 | 6,629 | 10,439 | 10,263 |
| TOTAL | $48,780 | $47,803 | $39,225 | $16,296 | $16,073 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 36,904 | 37,622 | 30,915 | N/A | N/A |
| Other Non-Current Liabilities | 2,059 | 2,628 | 1,122 | 101 | 3,325 |
| TOTAL | $2,059 | $38,006 | $56,501 | $2,834 | $6,058 |
| Total Liabilities | $50,839 | $85,809 | $95,726 | $19,130 | $22,131 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 15,863 | 7,503 | 5,483 | 4,327 | 4,008 |
| Common Shares | 16 | 7 | 5 | 4 | 48 |
| Retained earnings | -832,047 | -825,925 | -785,748 | -724,520 | -631,428 |
| Other shareholders' equity | -41 | -211 | -81 | -803 | -419 |
| TOTAL | $206,751 | $33,359 | $41,097 | $82,664 | $168,929 |
| Total Liabilities And Equity | $257,590 | $119,168 | $136,823 | $101,794 | $191,060 |